Page 8 - German Curevac News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Antes de las patentes de las vacunas anticovid, la urgencia son las materias primas
deperu.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from deperu.com Daily Mail and Mail on Sunday newspapers.
Antes de las patentes de las vacunas, la urgencia son las materias primas - La Razón
la-razon.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from la-razon.com Daily Mail and Mail on Sunday newspapers.
Antes de las patentes, urgen materias primas para las vacunas contra el COVID-19
elfinancierocr.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from elfinancierocr.com Daily Mail and Mail on Sunday newspapers.
Follow RT on The European medicines regulator has started a real-time review of Sinovac’s Covid-19 vaccine, with the drug becoming the first Chinese-developed jab to be evaluated by the bloc.
The launch of the so-called “rolling review” was announced by the European Medicines Agency (EMA) on Tuesday.
“The… decision to start the rolling review is based on preliminary results from laboratory studies (non-clinical data) and clinical studies. These studies suggest that the vaccine triggers the production of antibodies that target SARS-CoV-2, the virus that causes Covid-19, and may help protect against the disease,” the EMA said in a statement.
La EMA registra casos de trombos tras la administración de Pfizer y Moderna, pero no abre investigación
diariodeferrol.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from diariodeferrol.com Daily Mail and Mail on Sunday newspapers.